GNOM241220P12000
- 0.00
- 0.000.00%
Global X Fds Genomics & Biotechnology Etf Newsroom
Bernstein Maintains Market Perform on Arrowhead Pharma, Lowers Price Target to $24
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
Wednesday Ends With Index Decline | Wall Street Today
Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Arrowhead Pharmaceuticals Shares Are Trading Higher. Chardan Capital Maintained a Buy Rating on the Stock.
Chardan Capital Maintains Buy on Arrowhead Pharma, Maintains $60 Price Target
Arrowhead Pharma Analyst Ratings
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Sarepta Therapeutics Analyst Ratings
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Expert Outlook: Agilent Technologies Through The Eyes Of 4 Analysts
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs
Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On?
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday